Bio-Techne Corp (TECH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 288,228 | 290,376 | 269,276 | 257,719 | 259,028 |
| Cost of Goods | 87,878 | 88,918 | 85,585 | 86,722 | 83,083 |
| Gross Profit | 200,350 | 201,458 | 183,691 | 170,997 | 175,945 |
| Operating Expenses | 120,655 | 111,929 | 121,928 | 108,497 | 107,445 |
| Operating Income | 80,573 | 90,447 | 62,348 | 63,222 | 68,583 |
| Other Income | -1,521 | -21,675 | 23,831 | 4,161 | -61,469 |
| Pre-tax Income | 79,052 | 68,772 | 86,179 | 67,383 | 7,114 |
| Income Tax | 17,137 | 8,628 | 14,120 | -1,598 | -7,530 |
| Net Income Continuous | 61,915 | 60,144 | 72,059 | 68,981 | 14,644 |
| Minority Interests | 391 | -595 | -8,114 | -634 | -315 |
| Net Income | $61,524 | $60,739 | $80,173 | $69,615 | $14,959 |
| EPS Basic Total Ops | 0.39 | 0.39 | 0.51 | 0.45 | 0.10 |
| EPS Basic Continuous Ops | 0.39 | 0.38 | 0.46 | 0.44 | 0.09 |
| EPS Diluted Total Ops | 0.38 | 0.37 | 0.49 | 0.42 | 0.10 |
| EPS Diluted Continuous Ops | 0.38 | 0.37 | 0.44 | 0.42 | 0.09 |
| EBITDA(a) | $106,439 | $115,814 | $87,450 | $87,956 | $93,255 |